
Prescription — weekly injection pen
The FDA-approved semaglutide product for chronic weight management — a weekly injection pen, prescribed and titrated by a licensed provider.
Wegovy (semaglutide 2.4mg) is FDA-approved for chronic weight management in adults with obesity, or overweight with at least one weight-related condition, alongside diet and activity.
Adding to your plan doesn't order anything and doesn't charge you — it tells the provider what you're hoping to discuss.
About 5 minutes. A licensed provider reviews your health and prescribes wegovy® only if it's right for you — there is no checkout here, and that's deliberate.
How it works
Wegovy is semaglutide: a GLP-1 receptor agonist that mimics the fullness hormone your intestine releases after eating. It keeps that signal arriving between meals and slows stomach emptying, so smaller meals satisfy. As the manufacturer's finished product, every pen is produced and tested under FDA oversight — that is the practical difference between a branded medication and a compounded copy.
See the full mechanism, step by stepThe evidence
Published results, with what they were measured against. A number without a comparator isn't evidence — it's advertising.
14.9% mean body-weight reduction
vs 2.4% on placebo
Over 68 weeks at 2.4mg weekly, alongside lifestyle intervention, in adults with overweight or obesity without diabetes.
Wilding et al., STEP 1 trial, New England Journal of Medicine, 2021
Trial averages describe a study population, not a prediction for you. Your provider will be direct about what is realistic given your history — and results depend on continuing treatment.
A provider may consider it if
It won't be prescribed if
These are the same checks the visit runs. If one applies, the visit will tell you plainly rather than take your money.
What to expect
The 0.25mg starting dose exists to let your gut adapt — meaningful appetite effects usually arrive with the later steps.
The dose steps up on a set schedule (0.25 → 0.5 → 1 → 1.7 → 2.4mg weekly), with your provider checking tolerance at each stage.
This is managed as an ongoing condition. Stopping generally means the appetite effects stop too — plan that with your provider, not around them.
Safety, stated up front
Nausea, vomiting, diarrhoea, constipation and reflux are the common ones, usually worst after a dose increase. Serious but uncommon risks include pancreatitis, gallbladder problems and kidney injury from dehydration. The boxed warning covers thyroid C-cell tumors seen in rodents. Full prescribing information comes with every prescription.
Complete safety information is provided during your visit and with every prescription. This page is a summary, not a substitute for your provider's advice.
Questions
Same molecule, different product. Wegovy is the manufacturer's FDA-approved, dose-verified pen. A compounded version is prepared by a pharmacy and is not FDA-approved. Your provider can discuss both honestly.
Sometimes — coverage varies by plan and by state, and it changes the cost picture entirely. We'll show you the cash price before you pay anything; checking your coverage first is always worth it.
No — a licensed provider reviews your health history and prescribes only if it's appropriate and safe for you. If it isn't, we'll tell you why, and the medication portion of any payment is refunded.
Five minutes of questions, reviewed by a licensed provider. Treatment only if it's appropriate — and a straight answer either way.